Evaluate the Pharmacokinetics of BMS-986177 From Two Formulations in Healthy Participants

Summary

Assess the pharmacokinetics (fasting and fed), safety, and tolerability of BMS-986177 following oral dosing of Form A and Form B

Timeline

Start

2017-11-15

Primary completion

2017-12-28

Completion

2017-12-28

Drugs

Indications